|
|
 Presence in National & International market for more than two decades. |
| Multifunctional & Multicultural workforce of more than 5000 employees motivated towards higher standards of customer satisfaction. |
| 3200+ Stockiest pan India catering to over 60 Lakhs customers. |
| Long term supply alliances with reputed global companies in the markets of the US, Europe, Middle East,South East Asia, & African Markets |
| Joint ventures & Subsidiaries in Iran, Singapore, & Dubai, for establishing good network for international marketing. |
| Strong Presence in Europe, Middle East, US, CIS Countries. |
| Ranked 35th among top Indian Pharmaceuticals group in India. |
| Strong prescribing Doctor base of over 2.50Lacs. |
| Posses Portfolio of over 750 Products with presence in high growth therapeutic segments of Cardiology,Diabetology, Antidepressant, Anti-allergic, Anti-Infective, Neurology, Oncology. |
| World's largest manufacturer of Clarithromycin, Azithromycin and Fexofenadine. |
| Indswift Labs to be First Indian Company to Get PMDA approval from Japan |
| Winner of Many Prestigious Awards few of them are : |
| » Pharma Pulse Award for three consecutive years-2002-2005 |
| » Bharat Udhyog Rattan Award |
| » IDMA Quality Excellence Awards |
| » Deloitte Technology fast 500 Asia pacific Award in 2006 by Deloitte |
| » Udyog Rattan Award –For Valuable Contribution to Economic Development of HP |
| » Certificate of Excellence in recognition of Exemplary Growth and Sustainable Success by India Brand Equity Federation in Second Annual Inc. India 500 Awards. |
Possess state-of-the-Art manufacturing facilities for finished Dosage Forms & API's conforming to
the most Stringent International Norms WHO-GMP, TGA (Australia), MHRA (UK). |
| Manufacturing capacity (Finished Dosage) : |
| » 2300 million Tablets |
| » 64 million Ampoules |
| » 27 million Vials |
| » 84 million Capsules |
| » 18 million Dermatological products |
| » 62 million Oral liquid bottles |
|
